Literature DB >> 19657643

Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development.

Evis Sala1, Andrew N Priest, Masako Kataoka, Martin J Graves, Mary A McLean, Ilse Joubert, John R Griffiths, Robin A F Crawford, Mercedes Jimenez-Linan, Helena M Earl, James D Brenton, David J Lomas.   

Abstract

This prospective study aims to evaluate the feasibility of DWI at 3 Tesla in patients with advanced ovarian cancer and investigate the differences in vascular signal fraction (VSF) and apparent diffusion coefficient (ADC) values between primary ovarian mass and metastatic disease. Twenty patients with suspected advanced ovarian carcinoma were enrolled in the study. High-resolution T2W FRFSE images were used to confirm the position of three marker lesions: primary ovarian mass, omental cake and peritoneal deposit. Multislice DWI was acquired in a single breath-hold using multiple b-values. The three marker lesions were outlined by an experienced radiologist on ADC and VSF maps. Ovarian lesions showed the highest ADC values. The mean ADC value for peritoneal deposits was significantly lower than for both ovarian lesions (p = 0.03) and omental cake (p = 0.03). The VSF for omental cake was significantly higher than for ovarian lesions (p = 0.01) and peritoneal deposits (p = 0.04). There was a significant positive correlation between ADC and VSF for peritoneal deposits (p = 0.04). DWI in advanced ovarian cancer is feasible at 3 T. There are significant differences in baseline ADC and VSF values between ovarian cancer, omental cake and peritoneal deposits that may explain the mixed treatment response that occurs at different disease sites.

Entities:  

Mesh:

Year:  2009        PMID: 19657643     DOI: 10.1007/s00330-009-1543-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

2.  Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas.

Authors:  Tomohiro Nakayama; Kengo Yoshimitsu; Hiroyuki Irie; Hitoshi Aibe; Tsuyoshi Tajima; Akihiro Nishie; Yoshiki Asayama; Kunishige Matake; Daisuke Kakihara; Shuji Matsuura; Hitoo Nakano; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2005-08       Impact factor: 4.813

Review 3.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

Review 4.  Ovarian cancer: strategies for overcoming resistance to chemotherapy.

Authors:  Roshan Agarwal; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

5.  Magnetic resonance diffusion imaging of ovarian masses: a first experience with 12 cases.

Authors:  Gordon E Sarty; Edward J Kendall; John Loewy; Anita Dhir; Olufemi A Olatunbosun; Roger A Pierson
Journal:  MAGMA       Date:  2004-02-27       Impact factor: 2.310

6.  The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.

Authors:  Ken Tamai; Takashi Koyama; Tsuneo Saga; Nobuko Morisawa; Koji Fujimoto; Yoshiki Mikami; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-10-10       Impact factor: 5.315

7.  Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.

Authors:  Dennis S Chi; Pedro T Ramirez; Jerrold B Teitcher; Svetlana Mironov; Debra M Sarasohn; Revathy B Iyer; Eric L Eisenhauer; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Carol L Brown; Carol Aghajanian; David M Gershenson; William J Hoskins; Hedvig Hricak; Richard R Barakat
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

Review 8.  Role of diffusion-weighted imaging in the diagnosis of gynecological diseases.

Authors:  Tomohiro Namimoto; Kazuo Awai; Takeshi Nakaura; Yumi Yanaga; Toshinori Hirai; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2008-10-07       Impact factor: 5.315

9.  Diffusion-weighted MRI in cervical cancer.

Authors:  Patrick Z McVeigh; Aejaz M Syed; Michael Milosevic; Anthony Fyles; Masoom A Haider
Journal:  Eur Radiol       Date:  2008-01-12       Impact factor: 5.315

Review 10.  Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

Authors:  Daniel M Patterson; Anwar R Padhani; David J Collins
Journal:  Nat Clin Pract Oncol       Date:  2008-02-26
View more
  12 in total

1.  Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions.

Authors:  Bianka Chilla; Nik Hauser; Gad Singer; Mafalda Trippel; Johannes M Froehlich; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

Review 2.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

Review 3.  Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.

Authors:  Stavroula Kyriazi; Stan B Kaye; Nandita M deSouza
Journal:  Nat Rev Clin Oncol       Date:  2010-04-13       Impact factor: 66.675

4.  Diagnosis of Peritoneal Metastases with Abdominal Malignancies: Role of ADC Measurement on Diffusion Weighted MRI.

Authors:  Mehmet Ruhi Onur; Muammer Akyol; Ahmet Kursad Poyraz; Ercan Kocakoc; Erkin Ogur
Journal:  Eurasian J Med       Date:  2012-12

5.  Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors.

Authors:  Xinhua Fan; Hongbin Zhang; Shuang Meng; Jing Zhang; Chuge Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 6.  CT, MRI and PET imaging in peritoneal malignancy.

Authors:  Chirag M Patel; Anju Sahdev; Rodney H Reznek
Journal:  Cancer Imaging       Date:  2011-08-24       Impact factor: 3.909

7.  Modelling DW-MRI data from primary and metastatic ovarian tumours.

Authors:  Jessica M Winfield; Nandita M deSouza; Andrew N Priest; Jennifer C Wakefield; Charlotte Hodgkin; Susan Freeman; Matthew R Orton; David J Collins
Journal:  Eur Radiol       Date:  2015-01-21       Impact factor: 5.315

8.  Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.

Authors:  M E Pisanu; A Ricci; L Paris; E Surrentino; L Liliac; M Bagnoli; S Canevari; D Mezzanzanica; F Podo; E Iorio; R Canese
Journal:  Br J Cancer       Date:  2013-12-12       Impact factor: 7.640

Review 9.  In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer.

Authors:  Rossella Canese; Delia Mezzanzanica; Marina Bagnoli; Stefano Indraccolo; Silvana Canevari; Franca Podo; Egidio Iorio
Journal:  Front Oncol       Date:  2016-06-28       Impact factor: 6.244

Review 10.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.